T. Rowe Price Investment Management
KURA icon

T. Rowe Price Investment Management’s Kura Oncology KURA Stock Holding History

T. Rowe Price Investment Management’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-2,450,031
Closed -$30M – 579
2023
Q1 		$30M Sell
2,450,031
-218,533
-8% -$2.73M 0.02% 428
2022
Q4 		$33.1M Buy
2,668,564
+96,395
+4% +$1.4M 0.03% 409
2022
Q3 		$35.1M Buy
+2,572,169
New +$39.7M 0.03% 388

Other funds holding KURA

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

T. Rowe Price Investment Management's KURA Position: Q2 2023 in Review

T. Rowe Price Investment Management sold out of Kura Oncology (KURA) in Q2 2023, closing a stake of 2,450,031 shares — an estimated $30M sold.

T. Rowe Price Investment Management first reported a position in KURA in Q3 2022 and held it in 3 quarters. The position peaked at $35.1M in Q3 2022. 148 funds tracked by Wall St. Rank hold KURA as of Q2 2023.

  • T. Rowe Price Investment Management reported no remaining Kura Oncology position as of Q2 2023 after selling out during the quarter.
  • T. Rowe Price Investment Management sold 2,450,031 Kura Oncology shares in Q2 2023, an estimated $30M.
  • T. Rowe Price Investment Management first reported a position in Kura Oncology in Q3 2022 and held it in 3 quarters.
  • T. Rowe Price Investment Management's Kura Oncology position peaked at $35.1M in Q3 2022.
  • 148 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2023.

Based on T. Rowe Price Investment Management's 13F filing for Q2 2023, filed 14 Aug 2023.